Quality of life deficits offset benefits of preoperative rectal radiation therapy
Although preoperative radiotherapy has been shown to improve recurrence and mortality rates in patients with rectal cancer, a quality-of-life analysis by the same researchers suggests that male sexual dysfunction and fecal incontinence may be the trade-offs for those improved outcomes
Age dictates risk when neoadjuvant hormone therapy is added to prostate brachytherapy
The risks associated with neoadjuvant hormonal therapy may outweigh the benefits of its use in conjunction with brachytherapy in some older men with prostate cancer, according to research from the radiation oncology program at Boston’s Harvard Medical School.
Accelerated whole-breast irradiation does more with less after lumpectomy
Shortening the course of whole-breast irradiation aft er lumpectomy from fi ve weeks to three can improve convenience and cut costs without sacrificing results, according to research from McMaster University in Hamilton, Ontario.
Experts struggle with clinical implications of alcohol and link to breast cancer risk
Information on the relative health benefits and risks of alcohol consumption seems to come out on a monthly basis, but the early days of 2009 were particularly flooded with such reports. Three high-profile studies offered more evidence of a significant association between alcohol consumption and breast cancer risk.
Growth of Medicare HMOs could impact clinical trials
A study of Pittsburgh-area cancer patients suggests that many are opting out of clinical trials because, as members of Medicare HMO plans, they cannot afford the additional expense such trials entail.
Proton data suggest no greater risk of secondary malignancy
BOSTON-Retrospective data from Harvard Medical School and Massachusetts General Hospital may help alleviate fears that proton radiation therapy increases the risk of secondary cancer relative to conventional photon therapy.
Acupuncture matches antidepressant for vasomotor symptom relief
BOSTON-Acupuncture alleviates severe vasomotor symptoms as effectively as the antidepressant venlafaxine (Effexor) in breast cancer patients receiving anti-estrogen therapy, according to research from the Henry Ford Health System in Detroit.
Recurrence rates after accelerated partial breast RT on par with whole-breast RT
BOSTON-Accelerated partial breast irradiation using balloon brachytherapy drastically shortens treatment duration without aff ecting mortality and ipsilateral recurrence rates, according to three- and four-year follow-up data presented at ASTRO 2008.
Revamped quality assurance approach embarks on a new era in clinical trials
BOSTON-It’s no secret that quality assurance is essential for ensuring the accuracy of clinical trials. But the potential for real-time intervention also gives modern-era QA an unprecedented ability to improve outcomes, according to research presented at the ASTRO 2008 meeting (abstract 2576).
2 Clarke Drive Cranbury, NJ 08512